Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States

Introduction: Pharmacogenetics (PGx) has the potential to improve health outcomes but cost of testing is a barrier for equitable access. Reimbursement by insurance providers may lessen the financial burden for patients, but the extent to which PGx claims are covered in clinical practice has not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemke, Lauren K., Alam, Benish, Williams, Roy, Starostik, Petr, Cavallari, Larisa H., Cicali, Emily J., Wiisanen, Kristin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461057/
https://www.ncbi.nlm.nih.gov/pubmed/37645439
http://dx.doi.org/10.3389/fphar.2023.1179364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461057/
https://www.ncbi.nlm.nih.gov/pubmed/37645439
http://dx.doi.org/10.3389/fphar.2023.1179364

Ejemplares similares